NAFCIVET-DC®, a generic intramammary suspension, has been developed by the World-Vet R&D Laboratory to prevent mastitis during the dry period in dairy cattle. Designed specifically for dry cow therapy, the product targets both existing and new intramammary infections that may occur during the non-lactating phase.
The formulation combines three proven antibiotics:
- Procaine Benzylpenicillin G (300 mg)
- Dihydrostreptomycin (100 mg)
- Nafcillin (100 mg)
This combination provides broad-spectrum antibacterial coverage against both gram-positive and gram-negative pathogens commonly responsible for mastitis.
Key Advantages:
Triple-action efficacy
Combats a wide range of bacterial agents to help eliminate existing infections and prevent new ones
Up to 6 weeks of protection
Sustained action throughout the dry period, promoting udder health and reducing mastitis at calving
Formulated for dry cows
Specifically intended for use after the last milking, supporting recovery and preparation for the next lactation
Sterile pre-filled syringes
Each dose is delivered in a sterile, single-use intramammary syringe for safe, easy, and hygienic application
NAFCIVET-DC® DESIGNED TO DELIVER QUALITY BACKED BY SCIENCE
Produced under GMP and GLP standards, NAFCIVET-DC® reflects WORLD-VET’s commitment to high-quality, science-based veterinary solutions. It supports responsible antibiotic use and offers dairy producers an effective tool for reducing somatic cell counts, improving milk quality, and minimizing calving-related udder health issues.
For distribution proposals, please visit our Contact Us page.
